{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:17:18Z","timestamp":1784027838574,"version":"3.55.0"},"reference-count":60,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"the NIH","award":["5T32EB001631-07"],"award-info":[{"award-number":["5T32EB001631-07"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["CNS Oncol."],"published-print":{"date-parts":[[2014,11,30]]},"DOI":"10.2217\/cns.14.44","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T12:25:23Z","timestamp":1417523123000},"page":"407-419","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy"],"prefix":"10.1080","volume":"3","author":[{"suffix":"Jr","given":"Ramon Francisco","family":"Barajas","sequence":"first","affiliation":[{"name":"Department of Radiology &amp; Biomedical Imaging,University of California, San Francisco, 505 Parnassus Avenue, Long L200B, Box 0628, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonmee","family":"Cha","sequence":"additional","affiliation":[{"name":"Department of Radiology &amp; Biomedical Imaging,University of California, San Francisco, 505 Parnassus Avenue, Long L200B, Box 0628, San Francisco, CA 94143, USA"},{"name":"Department of Neurological Surgery,University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nop066"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280319"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.191.1.8134596"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.211.3.r99jn46791"},{"key":"e_1_3_3_7_1","first-page":"881","article-title":"Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin","volume":"21","author":"Cha S","year":"2000","unstructured":"Cha S , KnoppEA, JohnsonGet al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. Am. J. Neuroradiol.21, 881\u2013890 (2000).","journal-title":"Am. J. Neuroradiol."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199903000-00011"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002142-199904000-00004"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910060205"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910140211"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1954.6.12.731"},{"key":"e_1_3_3_13_1","unstructured":"Louis DN OhgakiH WiestlerOD CaveneeWK. WHO Classification of tumours of the central nervous system. IARC Lyon. (2008)."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(00)00274-4"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.171.6.9843274"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.09090663"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos128"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00795-004-0273-0"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(81)90188-X"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(81)90189-1"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0484"},{"key":"e_1_3_3_23_1","first-page":"7","article-title":"Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade","volume":"23","author":"Jackson A","year":"2002","unstructured":"Jackson A , KassnerA, Annesley-WilliamsD. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am. J. Neuroradiol.23, 7\u201314 (2002).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000215944.81730.18"},{"key":"e_1_3_3_25_1","first-page":"475","article-title":"Update on brain tumor imaging: from anatomy to physiology","volume":"27","author":"Cha S","year":"2006","unstructured":"Cha S . Update on brain tumor imaging: from anatomy to physiology. AJNR Am. J. Neuroradiol.27, 475\u2013487 (2006).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1052-5149(25)00561-1","article-title":"Clinical applications of intracranial perfusion MR imaging","volume":"9","author":"Lev MH","year":"1999","unstructured":"Lev MH , RosenBR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin. N. Am.9, 309\u2013331 (1999).","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"2","key":"e_1_3_3_27_1","first-page":"266","article-title":"Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging","volume":"26","author":"Cha S","year":"2005","unstructured":"Cha S , TihanT, CrawfordFet al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am. J. Neuroradiol.26(2), 266\u2013273 (2005).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"e_1_3_3_28_1","first-page":"839","article-title":"Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis","volume":"7","author":"Ino Y","year":"2001","unstructured":"Ino Y , BetenskyRA, ZlatescuMCet al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res.7, 839\u2013845 (2001).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.19.1473"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.636"},{"key":"e_1_3_3_31_1","first-page":"25","article-title":"Molecular pathology of oligodendroglial tumors. Recent results","volume":"171","author":"Hartmann C","year":"2009","unstructured":"Hartmann C , von DeimlingA. Molecular pathology of oligodendroglial tumors. Recent results. Cancer Res.171, 25\u201349 (2009).","journal-title":"Cancer Res."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3384"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-9880-x"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-006-0122-z"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20920"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3171\/JNS-07\/09\/0600"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2004.00600.x"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1737"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199912000-00034"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.0705"},{"issue":"20","key":"e_1_3_3_41_1","first-page":"6962","article-title":"Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme","volume":"63","author":"Shinojima N","year":"2003","unstructured":"Shinojima N , TadaK, ShiraishiSet al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res.63(20), 6962\u20136970 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.10.5724"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051918"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2009.08.004"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Choi BD ArcherGE MitchellDAet al. EGFRvIII-targeted vaccination therapy of malignant glioma. Brain Pathol. 19(4) 713\u2013723 (2009).","DOI":"10.1111\/j.1750-3639.2009.00318.x"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0141"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1022"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0713"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos073"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-014-0289-3"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280319"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:NEON.0000041871.46785.53"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006103010109"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.07.007"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.7.1277"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3541"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0b013e31820e1511"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10091440"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2532090007"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1377"}],"container-title":["CNS Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/cns.14.44","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:20:45Z","timestamp":1747174845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/cns.14.44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,30]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11,30]]}},"alternative-id":["10.2217\/cns.14.44"],"URL":"https:\/\/doi.org\/10.2217\/cns.14.44","relation":{},"ISSN":["2045-0907","2045-0915"],"issn-type":[{"value":"2045-0907","type":"print"},{"value":"2045-0915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icns20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icns20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-12-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}